Increased soluble ST2 is a stronger predictor of long-term cardiovascular death than natriuretic peptides in heart failure patients with reduced ejection fraction
- 1 March 2014
- journal article
- Published by Elsevier BV in International Journal of Cardiology
- Vol. 172 (1), e250-e252
- https://doi.org/10.1016/j.ijcard.2013.12.101
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- The Presage®ST2 Assay: analytical considerations and clinical applications for a high-sensitivity assay for measurement of soluble ST2Expert Review of Molecular Diagnostics, 2013
- Soluble ST2 protein in chronic heart failure is independent of traditional factorsVideosurgery and Other Miniinvasive Techniques, 2013
- Soluble ST2 is associated with adverse outcome in patients with heart failure of ischaemic aetiologyEuropean Journal of Heart Failure, 2012
- Combined use of high‐sensitivity ST2 and NTproBNP to improve the prediction of death in heart failureEuropean Journal of Heart Failure, 2012
- Cardiac remodeling—concepts and clinical implications: a consensus paper from an international forum on cardiac remodelingJournal of the American College of Cardiology, 2000